VIDEO-NET: Use of Video Consultation in Follow-up Care for Patients With a Neuroendocrine Tumor: a Feasibility Study

Sponsor
University Medical Center Groningen (Other)
Overall Status
Completed
CT.gov ID
NCT02147106
Collaborator
(none)
26
1
34
0.8

Study Details

Study Description

Brief Summary

Rationale: Patients with neuroendocrine tumors (NET) have a rare disease. Due to treating patients with a neuroendocrine tumor in 'NET knowledge centers' patients often have to travel long distances for follow-up visits at the outpatient clinic. Patients whose medical condition allows videoconsultation could save time by replacing outpatient clinic visits through videoconsultation for receiving follow-up care. Therefore, in this study we aim to introduce videoconsultation as a alternative for follow-up outpatient clinic visits in NET patients.

Objective: The primary objective is to assess if use of videoconsultation in follow-up care for NET patients is feasible. We hypothesize that videoconsultation is a suitable medium for providing follow-up care in NET patients. Secondary objectives are to explore the amount of time videoconsultation takes in comparison with outpatient clinic visits and the acceptability and satisfaction of physicians and patients with using videoconsultation in follow-up care.

Study design: The present study is a single-centre prospective feasibility study.

Study population: Adult NET patients under surveillance or treatment of the department Medical Oncology at the University Medical Centre Groningen (UMCG) whose medical condition allows videoconsultation will be invited to participate.

Intervention: Patient who give informed consent will participate in the study. Participants will receive follow-up care through videoconsultation instead of conventional visits at the outpatient clinic.

Main study parameters/endpoints: The main endpoint is the feasibility of videoconsultation for follow-up care in NET patients. We hypothesize that videoconsultation is a suitable medium for providing follow-up care.

Condition or Disease Intervention/Treatment Phase
  • Other: Videoconsultation

Study Design

Study Type:
Observational
Actual Enrollment :
26 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Use of Video Consultation in Follow-up Care for Patients With a NeuroEndocrine Tumor: a Feasibility Study (VIDEO-NET Study)
Study Start Date :
May 1, 2014
Actual Primary Completion Date :
Mar 1, 2017
Actual Study Completion Date :
Mar 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Videoconsultation

Performing two videoconsulations with the treating medical oncologist

Other: Videoconsultation

Outcome Measures

Primary Outcome Measures

  1. Feasibility [1 year]

    Participation rates, reason for declining participation, number of completed videoconsultations, dropout rate and reason for dropout will be noted in study records to evaluate feasibility of videoconsultation

Secondary Outcome Measures

  1. Amount of time [1 year]

    The amount of time NET patients are spending with videoconsultation in comparison with conventional outpatient clinic visits.

  2. Acceptability and satisfaction of patients [1 year]

    The acceptability and satisfaction of patients with the use of videoconsultation will be assessed with a questionnaire and open-ended questions.

  3. Acceptability and satisfaction of physicians [1 year]

    The acceptability and satisfaction of physicians with the use of videoconsultation will be assessed with a questionnaire and open-ended questions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Signed informed consent

  • Age ≥ 18 yrs

  • Grade I or II (low and intermediate grade) NET with any primary tumor type or disease stage

  • Have access to required equipment/technology for performing videoconsultation

Exclusion Criteria:
  • Newly referred NET patients, who are visiting the department of Medical Oncology at the UMCG for the first time

  • Recently diagnosed NET patients, who are in the diagnostic phase of the disease

  • NET patients who frequently require blood tests, consultation or physical examination

  • A hearing or visual impairment, which would make videoconsultation difficult

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Medical Center Groningen Groningen Netherlands 9713 GZ

Sponsors and Collaborators

  • University Medical Center Groningen

Investigators

  • Principal Investigator: A.M.E. Walenkamp, MD PhD, University Medical Center Groningen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
A.M.E. Walenkamp, MD PhD, University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT02147106
Other Study ID Numbers:
  • VIDEO-NET-2014
First Posted:
May 26, 2014
Last Update Posted:
May 5, 2017
Last Verified:
May 1, 2017
Keywords provided by A.M.E. Walenkamp, MD PhD, University Medical Center Groningen
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 5, 2017